Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease.
Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group. Takahashi K, et al. Among authors: yoshida m. Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2115-2126. doi: 10.2147/COPD.S268905. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32982204 Free PMC article. Clinical Trial.
Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease.
Imamura Y, Kawayama T, Kinoshita T, Sakazaki Y, Yoshida M, Takahashi K, Fujii K, Ando M, Hoshino T, Iwanaga T, Kohrogi H; Kyushu Asthma Seminar Investigators. Imamura Y, et al. Among authors: yoshida m. Allergol Int. 2017 Jul;66(3):482-484. doi: 10.1016/j.alit.2016.10.008. Epub 2016 Nov 22. Allergol Int. 2017. PMID: 27887878 Free article. No abstract available.
Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.
Toyama T, Kawayama T, Kinoshita T, Imamura Y, Yoshida M, Takahashi K, Fujii K, Higashimoto I, Hoshino T. Toyama T, et al. Among authors: yoshida m. Intern Med. 2019 Jan 15;58(2):175-185. doi: 10.2169/internalmedicine.0488-17. Epub 2018 Sep 12. Intern Med. 2019. PMID: 30210101 Free PMC article. Clinical Trial.
Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial.
Machida K, Kawayama T, Kinoshita M, Ichinose M, Tsuda T, Takata S, Koto H, Yoshida M, Ashihara Y, Kawashima M, Suna H, Inoue H. Machida K, et al. Among authors: yoshida m. Int J Chron Obstruct Pulmon Dis. 2019 Sep 19;14:2175-2184. doi: 10.2147/COPD.S223002. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31571853 Free PMC article. Clinical Trial.
11,103 results
You have reached the last available page of results. Please see the User Guide for more information.